Survey [inpr]
Efficacy [qlco]
TOLERABILITY [resa]
micronized fenofibrate [orch, phsu]
Patients [podg]
Dyslipidaemia [dsyn]
Objective [inpr]
Efficacy [qlco]
micronized fenofibrate [orch, phsu]
MILDLY [idcn]
Moderately [qlco]
Elevated [qlco]
Reduced [qlco]
Levels [qlco]
Methods [inpr]
Patients [podg]
Hyperlipidaemia [dsyn]
monitor [hlca]
Cities [geoa]
China [geoa]
treated [topp]
Daily [tmco]
micronized fenofibrate [orch, phsu]
Lipanthyl [orch, phsu]
mg% [qnco]
weeks [tmco]
Lipid level [lbtr]
treatment [ftcn]
Measured [qlco]
micronized fenofibrate [orch, phsu]
increased hdl [fndg]
Levels [qlco]
Correlated [qlco]
baseline [bodm]
Total patient population [qnco]
baseline [bodm]
HDL-1 [aapp, bacs, lipd]
mmol/L [qnco]
Patients [podg]
Group [idcn]
Patients [podg]
Observed [ftcn]
mmol/L [qnco]
mmol/L [qnco]
micronized fenofibrate [orch, phsu]
therapy [ftcn]
Decreased [qnco]
Following [tmco]
treatment [ftcn]
micronized fenofibrate [orch, phsu]
Correlated [qlco]
baseline [bodm]
General [spco]
Patients [podg]
Drug [phsu]
Conclusions [idcn]
Short-term [tmco]
treatment [ftcn]
micronized fenofibrate [orch, phsu]
Patients [podg]
Dyslipidaemia [dsyn]
MILDLY [idcn]
Moderately [qlco]
Elevated [qlco]
Expected [idcn]
Triglyceride level [lbtr]
